Evidence map›Paper›PMID 40579014›Full record

ArticleIn vivo (Athens, Greece)

A Case of Seronegative Lupus Nephritis Detected Incidentally by Renal Biopsy.

Akira Mima, Takamasa Matsuki, Takahiro Nakamoto, Yuta Saito, Takaaki Morikawa, Sakura Kure, Keishi Matsumoto, Shinji Lee

Abstract readCase Reports
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Akira MimaDepartment of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan akira.mima@ompu.ac.jp.
Takamasa MatsukiDepartment of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Takahiro NakamotoDepartment of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Yuta SaitoDepartment of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Takaaki MorikawaDepartment of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Sakura KureDepartment of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Keishi MatsumotoDepartment of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Shinji LeeDepartment of Nephrology, Osaka Medical and Pharmaceutical University, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimSystemic lupus erythematosus (SLE) and lupus nephritis (LN) are autoimmune diseases that affect multiple organ systems with the production of pathological autoantibodies. CASE REPORT: We describe the case of a 19-year-old man who had microscopic hematuria and mild proteinuria. No skin rash, joint symptoms, serositis, neuropathy, or cytopenia were observed. Renal biopsy revealed the thickness of the glomerular basement membrane, granular deposits of C1q along mesangial areas, and high electron density deposits in basement membrane on the epithelial side of the glomerulus. After operating renal biopsy, laboratory tests were performed and the results were not associated with SLE. This leads to the diagnosis of class V seronegative LN. The patient achieved remission only with angiotensin II receptor blocker without immunosuppressive drugs. There have been few reports of seronegative LN.

conclusionOur case report presents a case of seronegative LN identified incidentally during renal biopsy.

Indexed as

KidneyLupus NephritisBiopsyHumansIncidental FindingsLupus Erythematosus, SystemicMaleYoung AdultANA negativeseronegative lupus nephritisSystemic lupus erythematosus

Identifiers

PMID40579014
PMCPMC12223612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.